Literature DB >> 7641762

Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress.

D Lang1, F Hilger, J Binswanger, G Andelfinger, W Hartmann.   

Abstract

To evaluate the long-term effects of anthracyclines on the myocardium of the young child we examined 34 patients who had been treated with anthracyclines in childhood. In addition to anthracycline, the patients were treated with other potentially cardiotoxic substances within the framework of different protocols. The mean cumulative anthracycline dose was 128.6 mg/m2, the average age at onset of chemotherapy 4.2 years, and the time interval after discontinuation of treatment 9.0 years. The cardiological examination consisted of a physical examination, electrocardiography and echocardiography, including Doppler and bio-impedance cardiography. The patients were studied at rest and after physical exercise with a cycle ergometer test in a supine position. The results of the physical examination, the electrocardiogram at rest and the 24 h Holter monitoring were normal. The left ventricular enddiastolic diameter, shortening fraction, velocity of fibre shortening (VCF), the diastolic flow profile at the mitral valve level and the cardiac stroke volume at rest were also normal. However, the shortening fraction (SF) was below the margin of 2 standard deviations in two patients and the VCF in three patients. There was a significant reduction in septal thickness, (-1.4 SD, P < 0.0004), in the width of left ventricular posterior wall (-1.5 SD, P > 0.0002) and in the left ventricular myocardial mass (-0.76 SD, P = 0.0042). Physical working capacity was normal. Immediately after physical stress the expected rise of SF and VCF did not occur and the SF fell below the values at rest. In comparison to a healthy control group the SF and the VCF were markedly decreased (P > 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641762     DOI: 10.1007/bf02072099

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  17 in total

1.  Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer.

Authors:  A M Goorin; A R Chauvenet; A R Perez-Atayde; J Cruz; R McKone; S E Lipshultz
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

2.  Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults.

Authors:  S R Daniels; R A Meyer; Y C Liang; K E Bove
Journal:  J Am Coll Cardiol       Date:  1988-09       Impact factor: 24.094

3.  Determination of systemic vascular resistance by a noninvasive technic.

Authors:  M A Stefadouros; M J Dougherty; W Grossman; E Craige
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

4.  Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.

Authors:  G Hausdorf; G Morf; G Beron; R Erttmann; K Winkler; G Landbeck; E W Keck
Journal:  Br Heart J       Date:  1988-10

5.  Functional myocardial impairment in children treated with anthracyclines for cancer.

Authors:  S T Yeung; C Yoong; J Spink; A Galbraith; P J Smith
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

6.  Late, late doxorubicin cardiotoxicity.

Authors:  S L Gottlieb; W A Edmiston; L J Haywood
Journal:  Chest       Date:  1980-12       Impact factor: 9.410

7.  Cardiac toxicity 4 to 20 years after completing anthracycline therapy.

Authors:  L J Steinherz; P G Steinherz; C T Tan; G Heller; M L Murphy
Journal:  JAMA       Date:  1991-09-25       Impact factor: 56.272

8.  Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility.

Authors:  S D Colan; I A Parness; P J Spevak; S P Sanders
Journal:  J Am Coll Cardiol       Date:  1992-03-01       Impact factor: 24.094

9.  Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension.

Authors:  A R Snider; S S Gidding; A P Rocchini; A Rosenthal; M Dick; D C Crowley; J Peters
Journal:  Am J Cardiol       Date:  1985-12-01       Impact factor: 2.778

10.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

Authors:  S E Lipshultz; S D Colan; R D Gelber; A R Perez-Atayde; S E Sallan; S P Sanders
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

View more
  1 in total

1.  Exercise capacity in apparently healthy survivors of cancer.

Authors:  E De Caro; F Fioredda; M G Calevo; A Smeraldi; M Saitta; G Hanau; M Faraci; F Grisolia; G Dini; G Pongiglione; R Haupt
Journal:  Arch Dis Child       Date:  2005-09-27       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.